Enovis Total Liabilities 2012-2026 | ENOV
Enovis total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
Enovis Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $2,343 |
| 2024 | $2,154 |
| 2023 | $1,089 |
| 2022 | $823 |
| 2021 | $3,854 |
| 2020 | $3,764 |
| 2019 | $3,897 |
| 2018 | $3,139 |
| 2017 | $2,982 |
| 2016 | $3,245 |
| 2015 | $3,476 |
| 2014 | $3,859 |
| 2013 | $3,860 |
| 2012 | $3,992 |
| 2011 | $899 |
|
Enovis Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2026-06-30 | $2,287 |
| 2026-03-31 | $2,353 |
| 2025-12-31 | $2,343 |
| 2025-09-30 | $2,410 |
| 2025-06-30 | $2,440 |
| 2025-03-31 | $2,255 |
| 2024-12-31 | $2,154 |
| 2024-09-30 | $2,217 |
| 2024-06-30 | $2,153 |
| 2024-03-31 | $2,168 |
| 2023-12-31 | $1,089 |
| 2023-09-30 | $959 |
| 2023-06-30 | $993 |
| 2023-03-31 | $854 |
| 2022-12-31 | $823 |
| 2022-09-30 | $1,037 |
| 2022-06-30 | $1,012 |
| 2022-03-31 | $3,840 |
| 2021-12-31 | $3,854 |
| 2021-09-30 | $3,342 |
| 2021-06-30 | $3,208 |
| 2021-03-31 | $3,776 |
| 2020-12-31 | $3,764 |
| 2020-09-30 | $3,697 |
| 2020-06-30 | $3,727 |
| 2020-03-31 | $4,118 |
| 2019-12-31 | $3,897 |
| 2019-09-30 | $6,458 |
| 2019-06-30 | $6,643 |
| 2019-03-31 | $6,761 |
| 2018-12-31 | $3,139 |
| 2018-09-30 | $2,968 |
| 2018-06-30 | $2,925 |
| 2018-03-31 | $3,038 |
| 2017-12-31 | $2,982 |
| 2017-09-30 | $3,325 |
| 2017-06-30 | $3,358 |
| 2017-03-31 | $3,218 |
| 2016-12-31 | $3,245 |
| 2016-09-30 | $3,374 |
| 2016-06-30 | $3,418 |
| 2016-03-31 | $3,485 |
| 2015-12-31 | $3,476 |
| 2015-09-30 | $3,736 |
| 2015-06-30 | $3,581 |
| 2015-03-31 | $3,697 |
| 2014-12-31 | $3,859 |
| 2014-09-30 | $3,992 |
| 2014-06-30 | $4,278 |
| 2014-03-31 | $3,375 |
| 2013-12-31 | $3,860 |
| 2013-09-30 | $3,764 |
| 2013-06-30 | $3,690 |
| 2013-03-31 | $3,782 |
| 2012-12-31 | $3,992 |
| 2012-09-30 | $3,876 |
| 2012-06-30 | $3,901 |
| 2012-03-31 | $3,910 |
| 2011-12-31 | $899 |
| 2011-09-30 | $793 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.051B | $2.248B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |